Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease [Phase 1, Phase 2]

View source ↗

Summary

Early-phase trial investigating umbilical cord mesenchymal stem cells for moderate to severe chronic graft-versus-host disease. Phase 1/2 study with unknown sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shenzhen University General Hospital | Conditions: Graft Vs Host Disease | Phase 1, Phase 2 | Status: UNKNOWN